More headlines & perspectives
- By relevance
- By date
J&J expands oncology pipeline with $1 billion Firefly Bio deal
Top news
J&J to buy cancer drug technology developer Firefly Bio for $1 billion
By Puyaan Singh & Shinjini Ganguli
All coverage
J&J to buy cancer drug technology developer Firefly Bio for $1 billion
By Puyaan Singh & Shinjini Ganguli
J&J to buy cancer drug technology developer Firefly Bio for $1 billion
By Puyaan Singh & Shinjini Ganguli